TNYA’s Financial Health: Exploring Tenaya Therapeutics Inc’s Debt-to-Equity Ratio of 1.79

Tenaya Therapeutics Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $8.09 on 06/06/23, with the lowest value being $1.66 on 10/27/23.

52-week price history of TNYA Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Tenaya Therapeutics Inc’s current trading price is -29.80% away from its 52-week high, while its distance from the 52-week low is 242.17%. The stock’s price range for this period has remained between $1.66 and $8.09. The Healthcare sector company’s shares managed to surpass a trading volume of around 460.62 for the day, which was noticeably higher compared to the shares’ average daily volume of 1.16 over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Tenaya Therapeutics Inc (TNYA) has experienced a quarterly rise of 189.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 386.86M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.70, with a change in price of +2.75. Similarly, Tenaya Therapeutics Inc recorded 448,384 in trading volume during the last 100 days, posting a change of +94.19%.

TNYA Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TNYA stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.05.

TNYA Stock Stochastic Average

As of today, the raw stochastic average of Tenaya Therapeutics Inc over the past 50 days is 97.99%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 97.39%. Additionally, the Stochastic %K and %D values for the company were 79.47% and 69.95%, respectively, over the past 20 days.

TNYA Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 75.31%.However, over the last six months, we can see a weaker performance of 28.80%. Over the last 30 days, the price of TNYA has fallen by 79.75%. And in the last five days, it has surged by 24.84%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts